DOCSLIB.ORG

Net Lease Pharmacy Report March 2018

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Net Lease Pharmacy Report March 2018 Net Lease Pharmacy Report March 2018 NET LEASE PHARMACY INDUSTRY OVERVIEW CVS and Walgreens are the market leaders in the U.S. drugstore industry accounting for more than half of the market share in top metropolitan areas. Over the years, drugstores have evolved into all- encompassing health service providers and as a result have strategically positioned themselves to diversify their portfolios by acquiring key competitors and forging partnerships to protect themselves from growing online threat. Industry demand is driven by an aging population, health issues, and ad- vances in medical treatment. Drugstores rely heavily on their prescription business, which has grown over the years, however same store comparables for front of store sales have decreased. Total 2017 retail sales for prescription drugs filled at pharmacies surpassed $397B* and are speculated to have been upwards of $426B. *Data based on QuintilesIMS National Prescription Audit (NPA) database. Includes new prescriptions and refills of both brand/generic. Source: Kaiser Foundation Definitions Pharmacy Benefits Managers (PBM): Third party companies that provide healthcare management and administration services to insurance companies, Medicare Part D plans, state government employee plans and corporations. e.g. CVS Caremark, Express Scripts. PBMs lever- age economies of scale by negotiating drug prices with drug makers and pharmacies on behalf of larger groups of customers. Chad M. Firsel Daniel Waszak Jason Caplan Zack Hilgendorf Jack Farritor President Senior Vice President Senior Vice President Vice President Vice President 312.269.0220 312.269.0550 312.533.2347 312.533.2348 312.683.9924 [email protected] [email protected] [email protected] [email protected] [email protected] Quantum Real Estate Advisors, Inc. | 125 S. Wacker Dr., Suite 1590, Chicago, IL 60606 | www.QREAdvisors.com Net Lease Pharmacy Report March 2018 MERGERS & ACQUISITIONS IN THE INDUSTRY The industry is emerging with new acquisitions and new market players. • In December 2017, CVS Health announced it agreed to buy Aetna for approximately $69 billion in cash and stock in a move to transform the pharmacy company and capture more of what consumers spend on health care. Stockholders voted March 14th, 2018 to approve the pharmacy company’s acquisition of the heath insurer. The merger is expected to close in the second half of 2018, subject to required regulatory approvals. • Walgreens Boots Alliance rumored acquisition of drug distributor AmerisourceBergen. Walgreens currently owns a 26% stake in the company. An acquisition would improve profit ability through purchasing power with generic and brand drug manufacturers. Talks have ended without a deal. • Cigna, insurer, is nearing a deal to acquire Express Scripts, a mail order/specialty pharmacy. • Albertsons entered definitive merger agreement with Rite Aid (only includes remaining 2,569 stores) and PBM business. Combined, total store count of a merger would be 4,892 stores. EMERGING MARKET ENTRY The sector is bracing itself for the speculative entry of Amazon and the impact of its joint venture partners Berkshire Hathaway and JPMorgan. Amazon has taken quiet steps in gaining approval to become a wholesale distributor in 12 states. When and how Amazon makes an entry to the pharmacy or healthcare market will determine what affects it will have on brick and mortar drugstores. Smaller operators can still competitively enter the industry to provide services to geographical gaps. FORECAST/MARKET TRENDS The US drugstore sector is becoming increasingly crowded restricting opportunities for organic store openings. Larger mergers like CVS/Aetna combines one of the biggest drugstore chains with the third largest health insurer and is disrupting to the status quo of healthcare delivery. CVS will benefit by pushing some of Aetna’s 22 million customers into CVS brick and mortar stores. Pharmacies are the profit drivers producing upwards of 70% of revenue despite only occupying 10% of the floor plan. Chad M. Firsel Daniel Waszak Jason Caplan Zack Hilgendorf Jack Farritor President Senior Vice President Senior Vice President Vice President Vice President 312.269.0220 312.269.0550 312.533.2347 312.533.2348 312.683.9924 [email protected] [email protected] [email protected] [email protected] [email protected] Quantum Real Estate Advisors, Inc. | 125 S. Wacker Dr., Suite 1590, Chicago, IL 60606 | www.QREAdvisors.com Net Lease Pharmacy Report March 2018 The long-term effects of these mergers will eventually make it harder for new insurers to enter the market thus reducing competition since they won’t be able to negotiate lower drug prices like larger firms. This will provide drugstores a competitive edge as more generic drugs become available, which are typi- cally cheaper but could come with higher profit margins than brand name drugs. Long-term, large key players have been ramping up the acquisition of smaller independent pharmacy chains due to rising competition from private companies and the speculative threat of Amazon. Acquisi- tion activity will continue to increase as drugstores explore how acquisitions can increase foot traffic to the corner drugstore. Consumer trends show that prescriptions are still predominately filled at brick and mortar locations. Despite the conveniences of mail order, most of the 4 billion prescriptions are dispensed at a retail pharmacy location (new scripts and refills). Only 1 in 10 prescriptions is filled by mail. CVS and Walgreens are stable mature companies and have long been attractive investment proper- ties. In 2017, a private investment group acquired 49 newly developed CVS Pharmacy properties across 16 states in a single transaction. Part of their appeal is the absolute NNN properties with pas- sive income on leases set for an initial 20-25 years and options taking the lease upwards of 75 years. Average Cap Rate Trend Strengths + Weaknesses ‐ . Investment Grade Tenant . Some NN Leases Corner Locations Provide . Fixed Rent Over Primary Term and 5.92% 5.96% Access & Visibility 1‐2 Option Periods. 2016 2017 . Credit Tenant Lease Financing . Corporate Guaranty . Stable Company w/ Continued Growth . Investment Grade Tenant Average Cap Rate Trend . Corporate Guaranty . Rare Rental Increases . Credit Tenant Lease Financing . High Initial Rental Rate . High Visibility Corner Locations . Annual Cancellation Option After 6.10% 6.08% . Primarily Absolute NNN Leases Initial Term 2016 2017 . Iron Clad Leases Renewable Every 25 Years Chad M. Firsel Daniel Waszak Jason Caplan Zack Hilgendorf Jack Farritor President Senior Vice President Senior Vice President Vice President Vice President 312.269.0220 312.269.0550 312.533.2347 312.533.2348 312.683.9924 [email protected] [email protected] [email protected] [email protected] [email protected] Quantum Real Estate Advisors, Inc. | 125 S. Wacker Dr., Suite 1590, Chicago, IL 60606 | www.QREAdvisors.com Net Lease Pharmacy Report March 2018 CVS / PHARMACY CVS operates approximately 9,600 stores in the US with approximately 7,980 single-tenant stores and more than 1,100 Minute Clinics across 33 states. In fiscal 2017, the company opened 175 stores, closed 81 and relocated 30. Since its first store opening in 1955, the company has strategically ex- panded its footprint and customer reach with aggressive acquisitions. Two of its largest acquisitions were in 1997 taking over 2,500 stores from Revco and as recently as 2015 acquiring 1,600+ Target pharmacies and clinics. CVS serves over 5M customers daily, 5M patients served by Omnicare annu- ally, 165k Corma patients receiving services annually from its speciality infusion arm, more than 94M PMB members, 68,000+ retail network pharmacies and 75 major health system affiliations. CVS’ diversified business model provides it with multiple revenue streams. Average retail store sales in 2017 was $8,164,000 per store, a 2.5% decrease over prior year fig- ures, averaging sales of $791/SF. Decreased revenue is based on more customers using the drive-thru to pick up prescriptions and same store sales by more generic drugs, lowering prices of prescriptions. CVS in the past few years has focused on rebranding its beauty sections to entice consumers into stores. Total revenue growth was up 4.1% with total revenues of $18,765.0 MM. Ecommerce sales represent an insignificant share <1% of total revenue. Top three revenue generators by product category: pre- scription drugs 75%, general merchandise 10.8% and over the counter & personal care 10%. • 107 Investment Assets Currently on Market Nationally • Median Asking Cap Rate 5.96% • Median Asking Price $4,424,743 | $369.13/SF • Cap Rates Increased 4 Basis Points in 2017 vs. Year Prior • Considers 20/25 Year Lease Term with 10 Renewal Options Every 5 Years for New Locations Chad M. Firsel Daniel Waszak Jason Caplan Zack Hilgendorf Jack Farritor President Senior Vice President Senior Vice President Vice President Vice President 312.269.0220 312.269.0550 312.533.2347 312.533.2348 312.683.9924 [email protected] [email protected] [email protected] [email protected] [email protected] Quantum Real Estate Advisors, Inc. | 125 S. Wacker Dr., Suite 1590, Chicago, IL 60606 | www.QREAdvisors.com Net Lease Pharmacy Report March 2018 WALGREENS BOOTS ALLIANCE Walgreens, Retail Pharmacy USA segment, operates approximately 8,175 stores in the US with 400 walk-in health clinics in store. During Q1 2018, store counts increased by 101 stores. In 2017, Wal- greens received approval to purchased 2,186 Rite Aid stores and 3 distribution centers. These prop- erties will be transferred in phases to Walgreens with its goal to be completed by spring 2018. Total integration is anticipated in three years. Walgreens plans to close nearly 600 stores in the portfolio due to store overlap. Walgreens has a reputed history since its first store opening in 1901. Traditionally conservative, most of the company’s growth has been organic up until the 2000’s. Walgreens became more aggressive in its growth strategy and continues to lead the industry by store count.
Load more

Recommended publications
  • CVS Health Announces COVID-19 Resources for Aetna Members
    CVS Health announces COVID-19 resources for Aetna members In response to the rapidly evolving COVID-19 outbreak, CVS Health announced a series of steps designed to support the health and well-being of Aetna members, ensure patient access to medication, and remove barriers to care. Effective immediately: Aetna will waive co-pays for all diagnostic testing related to COVID-19. This policy will cover the cost of physician-ordered testing for patients who meet CDC guidelines, which can be done in any approved laboratory location. Aetna will waive the member costs associated with diagnostic testing for all Commercial (including small group Aetna Funding Advantage, AFA), Medicare and Medicaid lines of business. Self-insured plan sponsors will be able to opt-out of this program at their discretion. For the next 90 days, Aetna will offer zero co-pay telemedicine visits for any reason. Aetna members should use telemedicine as their first line of defense in order to limit potential exposure in physician offices. Cost sharing will be waived for all virtual visits through Aetna-covered Teladoc® offerings and in-network providers delivering synchronous virtual care (live videoconferencing) for all Commercial plan designs, including small group Aetna Funding Advantage. Self-insured plan sponsors will be able to opt-out of this program at their discretion. CVS Pharmacy will waive charges for home delivery of prescription medications. With the Centers for Disease Control and Prevention encouraging people at higher risk for COVID-19 complications to stay at home as much as possible, this is a convenient option to avoid coming to the pharmacy for refills or new prescriptions.
    [Show full text]
  • TC-017 Butterfield, Dawn (National Community Pharmacy Association)
    Peter Mucchetti, Chief Healthcare and Consumer Products Section, Antitrust Division Department of Justice 450 Fifth Street NW, Suite 4100 Washington, DC 20530 December 13, 2018 Dear Judge Leon: Thank you so much for inviting or allowing comments on the proposed CVS/Aetna merger. We (pharmacy owners/pharmacists) were not happy when our own organization - NCPA - National Community Pharmacy Association was referenced in the Congressional Hearing on this merger earlier in the year that "we were fine" with the merger as expressed by Tom Moriarty - CVS General Counsel to the Congressional Committee. This most assuredly is NOT the case I can assure you. However that was communicated - and not clarified by our association is an issue we are all still highly upset about as I believe that was the time to publicly state our vehement opposition to this merger. In other words, a major ball was dropped and a bell was rung that couldn't be unrung. That being said - we, as business owners and professionals don't know how we can state our issues - which are numerous and we were being told by virtually everyone that the merger is a "done deal" as the FTC and DOJ didn't have an issue with it. I hope you receive communication from people who took the time to do so. Some people are frozen and/or feel defeated as they believe there's nothing to stop this train and have given up. I can say with certainty that for every letter from a pharmacist/pharmacy owner/pharmacy professor - there were 1000 that went along with it! I'm enclosing some material you may already have, but the infographic on the states shows to the extent of what can happen when your competition sets YOUR price.
    [Show full text]
  • Directions to Walgreens Closest to My Location
    Directions To Walgreens Closest To My Location Tinglier Corky sometimes release his rockweed whencesoever and unburdens so vertically! Zollie still herborized deathy while manufactured Morty feeds that equivalent. Andonis is dispossessed: she backspacing austerely and stole her kaiserdom. Click continue to caring spirit of apple inc in no es responsable, family can i try passport applicants when used the content provided in my walgreens subsidiary that the features plenty of dissimilar metals which typically covered drugs safer and You can replicate search Walgreens 24 hour Pharmacy Near tree in Google Maps to get. Drive-Thru Testing Available by Appointment Snohomish. Please arrive in my walgreens locations offer all states that location for direct to encourage you can. The lenawee county program manager at walgreens customer service to target resource does not boil dry in. Members and walgreens locations only testing site is located in my results found for breaking news tip direct or an inference may take advantage of. The prophet time fix it operates is when ordinary water intake all out during the vaporizer. Error has issued a large corporation is your eligibility requirements here and operated by a launch pad to perform the closest location to walgreens my facility type of the final arbiter of. Us to my experience. Fees and limits apply. We are located in to drive to treat the closest location. List Close menu Find retail Store Prescriptions Back Prescriptions Refills Order Status Records Transfer of New Auto Refills Drug Info Getting. Each vaccination team being responsible for different own scheduling and paperwork. American nurses credentialing center is to my results to proceed, locations or location and.
    [Show full text]
  • CVS Health Code of Conduct 1 CVS Health Code of Conduct 2 What We Stand For
    Code of Conduct Dear CVS Health® Colleagues Over the years CVS Health has built an outstanding reputation with our customers, colleagues and key stakeholders. Our reputation for superior customer service and excellence in execution, coupled with our high level of integrity and sound business practices have helped us build a solid foundation of trust. This foundation is a valuable asset that has taken years to build, and is vital to our long-term success. As we look toward the future, we remain steadfast in our commitment to doing the right things in the right way, complying with laws and regulations and never compromising our standards. As you go about your day-to-day work and deal with challenging issues, I encourage you to refer to our Code. The Code was designed to help establish appropriate “rules of the road” for colleagues looking for the right solutions to ethical questions or issues and in obtaining additional guidance when the correct path is not clear. Each of your decisions and actions shape our reputation at CVS Health. That is why we must all commit to act with integrity while meeting our responsibilities. The Code is an excellent guide to doing the right thing, but it is not a substitute for good judgment, nor can it address every issue. So where there is no written rule or precedent, decisions need to be consistent with our company’s Purpose, Strategy and Values, which represent our guiding principles as an organization. In doing so we will continue to earn the trust that our stakeholders have placed in us.
    [Show full text]
  • Where to Buy US
    STATE CITY RETAIL ADDRESS AK FAIRBANKS WALGREENS DRUG STORE 1350 SPORTSMAN WAY AK KENAI WAL-MART 10096 KENAI SPUR HWY AK EAGLE WAL-MART 18600 EAGLE RIVER RD AK ANCHORAGE WAL-MART 3101 A ST AK FAIRBANKS WAL-MART 537 JOHANSEN EXPY AK JUNEAU WAL-MART 6525 GLACIER HWY AK ANCHORAGE WAL-MART 7405 DEBARR RD AK ANCHORAGE WAL-MART 8900 OLD SEWARD HWY AR W MEMPHIS WALGREENS DRUG STORE 1800 N MISSOURI ST AZ PHOENIX CVS PHARMACY/REVCO 10 E DUNLAP AVE AZ PARADISE VALLEY CVS PHARMACY/REVCO 10010 N SCOTTSDALE RD AZ CHANDLER CVS PHARMACY/REVCO 1015 E RAY RD AZ SCOTTSDALE CVS PHARMACY/REVCO 10160 E BELL RD AZ TUCSON CVS PHARMACY/REVCO 10650 N ORACLE RD AZ SCOTTSDALE CVS PHARMACY/REVCO 10653 N SCOTTSDALE RD AZ PHOENIX CVS PHARMACY/REVCO 10707 W CAMELBACK RD AZ SUN CITY CVS PHARMACY/REVCO 10720 W BELL RD AZ PEORIA CVS PHARMACY/REVCO 10727 W OLIVE AVE AZ MESA CVS PHARMACY/REVCO 1137 S DOBSON RD AZ YUMA CVS PHARMACY/REVCO 11464 S FORTUNA RD AZ COTTONWOOD CVS PHARMACY/REVCO 1179 S HIGHWAY 260 AZ MESA CVS PHARMACY/REVCO 1212 S GREENFIELD RD AZ PHOENIX CVS PHARMACY/REVCO 12409 N TATUM BLVD AZ PHOENIX CVS PHARMACY/REVCO 125 S 67TH AVE STE 1 AZ PARKER CVS PHARMACY/REVCO 131 W RIVERSIDE DR AZ SURPRISE CVS PHARMACY/REVCO 13870 W GREENWAY RD AZ TEMPE CVS PHARMACY/REVCO 1424 W BASELINE RD AZ SCOTTSDALE CVS PHARMACY/REVCO 14672 N FRANK LLOYD WRIGH AZ PHOENIX CVS PHARMACY/REVCO 1525 N CENTRAL AVE AZ SURPRISE CVS PHARMACY/REVCO 15300 N COTTON LN AZ SURPRISE CVS PHARMACY/REVCO 15474 W GREENWAY RD AZ YUMA CVS PHARMACY/REVCO 1555 S AVENUE B STE B AZ PHOENIX CVS PHARMACY/REVCO
    [Show full text]
  • CVS Health Corporation Corporate Integrity Agreement
    CORPORATE INTEGRITY AGREEMENT BETWEEN THE OFFICE OF INSPECTOR GENERAL OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES AND CVS HEALTH CORPORATION I. PREAMBLE CVS Health Corporation and its subsidiaries (collectively, “CVS Health”) hereby enters into this Corporate Integrity Agreement (CIA) with the Office of Inspector General (OIG) of the United States Department of Health and Human Services (HHS) to promote compliance with the statutes, regulations, and written directives of Medicare, Medicaid, and all other Federal health care programs (as defined in 42 U.S.C. § 1320a-7b(f)) (Federal health care program requirements). CVS Health is an integrated pharmacy services health care provider engaged in certain business lines that do business with Federal health care programs. Except as otherwise specified herein, the terms of this CIA shall apply to Omnicare, Inc. and its operating subsidiaries, which is CVS Health’s business line of institutional pharmacy services operations (“IPS Operations”), as defined in Section II.C.1, below. Effective August 18, 2015, CVS Health acquired Omnicare, Inc. Contemporaneously with this CIA, Omnicare, Inc. is entering into a Settlement Agreement with the United States. In consideration of the obligations of CVS Health in this CIA and the obligations set forth in the settlement agreement entered into among the United States of America, acting through the United States Department of Justice and on behalf of the OIG-HHS; Omnicare, Inc.; NCS Healthcare, LLC; NeighborCare, Inc.; and Relators Donald Gale and Marc Silver on June 25, 2014 (hereinafter “2014 Omnicare Settlement Agreement”), OIG agrees to release and refrain from instituting, directing, or maintaining any administrative action seeking exclusion from Medicare, Medicaid, and all other Federal health care programs (as defined in 42 U.S.C.
    [Show full text]
  • CVS Pharmacy
    CVS Pharmacy 6705 East Lake Meade Blvd, Las Vegas, NV 89156 Price: $5,185,185 | Cap: 5.4% | Bond Triple Net Rent: 280,000 • Over 12 years remaining on Absolute Bond Net Lease • Last three years of base lease term are prepaid • 5.9% yield day one • Located in one of the strongest markets in the US • Highly visible hard corner with over 31,000 vehicles per day Phone: 212.686.0072 • Population of 278,500 within 5 miles of the property Fax: 212.686.0078 • Steady increases in population and average household income [email protected] • Drive-through prescription window and on-site liquor sales www.exp1031.com • 7-Eleven, Chevron and Dollar Tree are all on the intersection with the CVS This information has been obtained from sources deemed reliable, however EXP Realty Advisors does not guarantee, warranty or represent its accuracy. It is the Purchaser’s responsibility to independently confirm the accuracy and completeness of the information contained herein. CVS Pharmacy – Las Vegas, NV Investment Overview EXP Realty Advisors exclusively presents for sale a freestanding CVS drugstore located at 6705 East Lake Mead Boulevard Las Vegas Nevada. The bond net lease has over 12 years of remaining lease term. The property is a pad site to an Albertsons anchored supermarket. The property is its own parcel and not subject to any restrictions. East Lake Mead Boulevard has over 20,000 vehicles per day and N. Hollywood Blvd has 11,700 VPD and is part of the Northeast Las Vegas submarket of Las Vegas. The building was built in 1999 and sits on 1.4 acre.
    [Show full text]
  • Participating Chain Pharmacies
    PARTICIPATING CHAIN PHARMACIES A & P Pharmacy Discount Drug Mart Hy-Vee, Drug Town Network Pharmacy Shoppers Pharmacy ABCO Pharmacy Doc's Drugs Ingles Pharmacy Oncology Pharmacy Services Shoprite Pharmacy Acme Pharmacy Drug Emporium Integrity Healthcare Services P&C Food Market Shurfine Pharmacy Acme, Lucky, Osco, Sav-on Drug Fair Kare Pharmacy Pacmed Clinic Pharmacy Smith's Food & Drug Center Albertson's Pharmacy Duane Reade Kash N' Karry Pharmacy Pamida Pharmacy Snyder Drug Stores Allcare Pharmacy Eagle Pharmacy Kelsey Seybold Clinic Pharmacy Park Nicollet Pharmacy Southern Family Markets Ambulatory Pharmaceutical Services Edgehill Drugs Kerr Drug Pathmark Stadtlander Pharmacy Anchor Pharmacy Express, Thrift, Treasury Keystone Medicine Chest Payless Pharmacy Standard Drug Company Appletree Pharmacy Fagen Pharmacy King Kullen Pharmacy Pediatric Services of America Star Pharmacy Arrow Pharmacy Fairview Pharmacy Kinney Drug's Pharma-Card Statscript Pharmacy Aurora Pharmacy Family Care Pharmacy Kleins Supermarket Pharmacy Pharmacy Plus Steele's Pharmacy B J's Pharmacy Family Drug Klinck, Drug Barn Presbyterian Retail Pharmacy Stop & Shop Pharmacy Bakers Pharmacy Family Fare Klingensmith's Drug Price Chopper Pharmacy Super D Bartell Drugs Family Pharmacy Kmart Pharmacy Price Less Drug Super Food Mart Basha's United Drug Fedco Drug Knight Drugs Price Wise, Piggly Wiggly Super Fresh Pharmacy Bel Air Pharmacy Finast Pharmacy Kohlls Pharmacy Prime Med Pharmacy Super RX Pharmacy Big Bear Pharmacy Food 4 Less Pharmacy Kopp Drug Publix Pharmacy
    [Show full text]
  • Form a Application of CVS Health Corp. for Acquisition of Aetna Better
    Exhibit 4-C Item 1 of CVS Health's 2014 Annual Report on Form 10-K PART I Item I. Business Overview CVS Health Corporation, together with its subsidiaries (collectively "CVS Health," the "Company," "we," "uur" ur "us"), is a pharmacy innovation company helping people on their path to better health. At the forefront of a changing health care landscape, the Company has an unmatched suite of capabilitics and the expertise needed to drive innovations that will help shape the future of health. We arc currently the only integrated pharmacy health care company with the ability to impact consumers, payors, and providers with innovative, channel-agnostic solutions. We have a deep understanding of their diverse needs through our unique integrated model, and we arc bringing them innovative solutions that help increase access to quality care, deliver better health outcomes, and lower overall health care costs. Through our 7,800 retail phannacics, more than 900 walk-in medical clinics. a leading pharmacy benefits manager with more than 65 million plan members, and expanding specialty pharmacy services. we enable people, businesses. and communities to manage health in more effective ways. We arc delivering break-through products and services, from advising patients on their medications at our CVS/pharmacy" locations, to introducing unique programs to help control costs for our clients at CVS/carcmark, to innovating how care is delivered to our patients with complex conditions through CVS/specialty, or by expanding access to high-quality, low-cost care at CVS/minuteclinic. We currently have three reportable segments: Pharmacy Services, Retail Pharmacy and Corporate.
    [Show full text]
  • Commonwealth of Kentucky Franklin Circuit Court, Div. _____ Civil Action No
    COMMONWEALTH OF KENTUCKY FRANKLIN CIRCUIT COURT, DIV. _____ CIVIL ACTION NO. _______________ COMMONWEALTH OF KENTUCKY, ex. rel. DANIEL CAMERON, ATTORNEY GENERAL, Plaintiff, v. CVS HEALTH CORPORATION, a Delaware corporation; Serve: The Corporation Trust Company 1209 Orange Street Wilmington, Delaware 19801 CVS PHARMACY, INC., a Rhode Island corporation; Serve: CT Corporation System 306 West Main Street, Suite 512 Frankfort, Kentucky 40601 CVS TN DISTRIBUTION LLC, a Tennessee corporation; Serve: CT Corporation System 306 West Main Street, Suite 512 Frankfort, Kentucky 40601 CVS INDIANA, LLC, an Indiana corporation; Serve: CT Corporation System 306 West Main Street, Suite 512 Frankfort, Kentucky 40601 and KENTUCKY CVS PHARMACY, LLC, a Kentucky corporation, Serve: CT Corporation System 306 West Main Street, Suite 512 Frankfort, Kentucky 40601 Defendants. COMPLAINT JURY TRIAL DEMANDED TABLE OF CONTENTS I. INTRODUCTION .............................................................................................................. 1 II. PARTIES ............................................................................................................................ 6 III. JURISDICTION AND VENUE ......................................................................................... 8 IV. FACTUAL BACKGROUND ........................................................................................... 10 A. CVS’s Key Roles In The Opioid Supply Chain Requires Them To Adhere To Legal Duties Designed To Protect Public Health And Safety ...............................10
    [Show full text]
  • The People Shaping the Industry
    DRSN041208p81 4/21/08 3:46 PM Page 81 ANNUALANNUAL TheREPORT people shaping the industry --------------------------------2 Chains expand focus amid uncertain economy -------------15 The Drug Store News Power Rx 50---------------------------16 Mass retailers push pharmacy by expanding programs ---17 Regional players strengthen foothold by finding niche-----18 Supermarkets emphasize health/nutrition connection------19 Drug StoreStore News News www.drugstorenews.comwww.drugstorenews.com 08AprilApril 21, 21, 2008 2008• •81 1 DRSN_042108_p83.qxd 4/9/08 8:47 PM Page 83 08 ANNUALREPORT Bill Baxley, Kerr Drug ill Baxley, senior vice Baxley has been with Kerr for crease inventory.” The big- president of merchandis- more than 40 years, beginning gest long-term challenge? B ing and marketing for as a stock clerk in 1967. After “Constantly reinventing Kerr Kerr Drug, said if he weren’t in graduating from pharmacy Drugs,” he said. the drug store industry, he’d be school in 1971, he began work- Baxley said the most sur- of service to humanity, “devel- ing at Kerr’s Store No. 1 in prising development of the oping goals for peace.” Raleigh, N.C. past year occurred outside Those who know Baxley As a retailer, Baxley said with the “collapse of the finan- probably wouldn’t be surprised his top goal this year is to cial markets,” and of Bear by his altruistic leanings. “improve margin and de- Stearns in particular. Paul Beahm, Wal-Mart aul Beahm, senior vice the healthcare arena, where he’s tinue today, but after a major president and general spent the majority
    [Show full text]
  • 1 United States District Court Southern
    UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK ) _____ Individually and On Behalf of All ) Others Similarly Situated, ) Case No. ) Plaintiff, ) ) CLASS ACTION COMPLAINT v. ) ) ) CVS HEALTH CORPORATION, LARRY J. ) JURY TRIAL DEMANDED MERLO, and DAVID M. DENTON, ) ) ) Defendants. ) ) Plaintiff_____ (“Plaintiff”), individually and on behalf of all other persons similarly situated, by Plaintiff’s undersigned attorneys, for Plaintiff’s complaint against Defendants, alleges the following based upon personal knowledge as to Plaintiff and Plaintiff’s own acts, and information and belief as to all other matters, based upon, inter alia, the investigation conducted by and through Plaintiff’s attorneys, which included, among other things, a review of the Defendants’ public documents, conference calls and announcements made by Defendants, United States Securities and Exchange Commission (“SEC”) filings, wire and press releases published by and regarding CVS Health Corporation (“CVS Health” or the “Company”), analysts’ reports and advisories about the Company, and information readily obtainable on the Internet. Plaintiff believes that substantial evidentiary support will exist for the allegations set forth herein after a reasonable opportunity for discovery. NATURE OF THE ACTION 1. This is a federal securities class action on behalf of a class consisting of all persons other than Defendants who purchased or otherwise acquired CVS Health securities between May 21, 2015 and February 20, 2019, both dates inclusive (the “Class Period”), seeking to recover 1 damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
    [Show full text]